- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03670524
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project (HEAL)
November 28, 2023 updated by: Rachel Keith, University of Louisville
The purpose of this study is to examine how the environment and neighborhood characteristics affects the health of the area residents.
The study will help determine how changing neighborhood characteristics, such as green space, affect heart health, risk factors for other diseases, sense of well- being or neighborhood cohesion.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
835
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jackie Research Coordinator, MS
- Phone Number: 502-852-6167
- Email: jacqueline.gallagher@louisville.edu
Study Locations
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- Recruiting
- University of Louisville
-
Contact:
- Jackie Gallagher, MS
- Phone Number: 502-852-6167
- Email: jacqueline.gallagher@louisville.edu
-
Principal Investigator:
- Rachel Keith, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 30-70 years of age.
- Live within the targeted study location
Exclusion Criteria:
- Unwilling or unable to provide consent.
- HIV/AIDS, active treatment for cancer, active bleeding including wounds.
- Body weight less than 100 pounds or BMI>40.
- Prisoners and other vulnerable populations.
- Anyone that PI thinks is unsafe to participate in study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control Group
No intervention
|
|
Experimental: Targeted neighborhoods for Greenness
Using greenness as a therapeutic intervention, we will plant shrubs, grasses, young and mature trees (40-50 ft in height), so that we can evaluate changes in health and pollution, 2 years after planting.
|
Greenness to be used as a therapeutic intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiovascular Measurements. Change from Baseline Systolic and Diastolic pressures at baseline and 2 year followup.
Time Frame: Baseline and 2 year followup
|
Blood pressure mm Hg
|
Baseline and 2 year followup
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pulse Wave Analysis. Assess change from baseline arterial stiffness measurement and 2 year followup.
Time Frame: Baseline and 2 year followup
|
Augmentation index-percent
|
Baseline and 2 year followup
|
Physical Exam
Time Frame: Baseline and 2 year followup
|
Body weight-pounds
|
Baseline and 2 year followup
|
Body lean mass
Time Frame: Baseline and 2 year followup
|
Body lean mass to be measured in pounds
|
Baseline and 2 year followup
|
Body fat
Time Frame: Baseline and 2 year followup
|
Body fat to be measured in percentage
|
Baseline and 2 year followup
|
Standing height
Time Frame: Baseline and 2 year followup
|
standing height reported in inches
|
Baseline and 2 year followup
|
Waist, Hip measurement
Time Frame: Baseline and 2 year followup
|
central adiposity (waist circumference, and hip circumference to be measured in inches
|
Baseline and 2 year followup
|
Respiratory status will be evaluated
Time Frame: Baseline and 2 year followup
|
Fleisch-type pneumotachometer used to evaluate FEV1 and FVC percentages
|
Baseline and 2 year followup
|
Bucchal swab
Time Frame: Baseline and 2 year followup
|
Assess oral microbiome and DNA from cheek swab will be stored for genetic phenotyping.
|
Baseline and 2 year followup
|
Urine collection
Time Frame: Baseline and 2 year followup
|
metabolites of environmental volatile organic compounds ng/mg creatinine, biogenic VOCs and nicotine metabolites ng/mg creatinine, catecholamines ng/mg creatinine
|
Baseline and 2 year followup
|
Lipids
Time Frame: Baseline and 2 year followup
|
LDL-mg/dl, HDL-mg/dl, total cholesterol-mg/dl
|
Baseline and 2 year followup
|
Toenail samples
Time Frame: Baseline and 2 year followup
|
Toenail samples to look for heavy metal exposure
|
Baseline and 2 year followup
|
Hair samples
Time Frame: Baseline and 2 year followup
|
Hair samples to look at cortisol levels over time.
|
Baseline and 2 year followup
|
Perceived stress scale-PSS-10 range 0-40
Time Frame: Baseline and 2 year followup
|
The higher the score the more perceived stress
|
Baseline and 2 year followup
|
Depression-Patient Health Questionnaire (PHQ-9) 0-27
Time Frame: Baseline and 2 year followup
|
The 0-4= none; 5-9= Mild, 10-14= Moderate; 15-19= moderately severe; 20-27= severe.
The higher the score the more severe the depression.
|
Baseline and 2 year followup
|
Well-being assessment-Questionnaire 13-65
Time Frame: Baseline and 2 year followup
|
Warwick-Edinburgh Mental Well-being scale 13-65.
The higher the score the higher the sense of well-being.
|
Baseline and 2 year followup
|
Health perception
Time Frame: Baseline and 2 year followup
|
Health perception questionnaire
|
Baseline and 2 year followup
|
National Health Interview Survey tobacco questionnaire
Time Frame: Baseline and 2 year followup
|
National Health Interview Survey tobacco questionnaire
|
Baseline and 2 year followup
|
The Alcohol Use disorders identification test (AUDIT)- Range 0-40
Time Frame: Baseline and 2 year followup
|
Scores of 8-15 or more are recommended indicators of hazardous and harmful alcohol use or possible alcohol dependence.
Women can be lowered to a score of 7 for concern.
Scores of 16-19 suggest a need for brief counseling and continues monitoring.
Scores of 20 or above warrant diagnostic evaluation for alcohol dependence.
|
Baseline and 2 year followup
|
Self reported physical activity 1
Time Frame: Baseline and 2 year followup
|
times per week
|
Baseline and 2 year followup
|
Self reported physical activity 2
Time Frame: Baseline and 2 year followup
|
Exertion level of mild moderate or vigorous
|
Baseline and 2 year followup
|
Self reported education
Time Frame: Baseline and 2 year followup
|
Education to be reported by last school grade completed
|
Baseline and 2 year followup
|
Self reported annual income
Time Frame: Baseline and 2 year followup
|
Annual income reported by dollars
|
Baseline and 2 year followup
|
Platelet count
Time Frame: Baseline and 2 year followup
|
cells/cubic millimeter
|
Baseline and 2 year followup
|
Complete Blood Count 1
Time Frame: Baseline and 2 year followup
|
White/Red blood cell count- cells per cubic millimeter
|
Baseline and 2 year followup
|
Complete Blood Count 2
Time Frame: Baseline and 2 year followup
|
Hemoglobin-grams/deciliter
|
Baseline and 2 year followup
|
Complete Blood Count 3
Time Frame: Baseline and 2 year followup
|
Hematocrit-percentage
|
Baseline and 2 year followup
|
Liver function
Time Frame: Baseline and 2 year followup
|
AST, ALT units per liter
|
Baseline and 2 year followup
|
C-Reactive Protein
Time Frame: Baseline and 2 year followup
|
Hs-CRP-mg/Liter
|
Baseline and 2 year followup
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Aruni Bhatnagar, PhD, University of Louisville
- Principal Investigator: Rachel Keith, PhD, University of Louisville
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 3, 2018
Primary Completion (Estimated)
October 1, 2025
Study Completion (Estimated)
October 30, 2026
Study Registration Dates
First Submitted
August 31, 2018
First Submitted That Met QC Criteria
September 12, 2018
First Posted (Actual)
September 13, 2018
Study Record Updates
Last Update Posted (Actual)
November 29, 2023
Last Update Submitted That Met QC Criteria
November 28, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15.1260
- R01ES029846-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruitingCardiovascular DiseaseUnited States
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Penn State UniversityCalifornia Healthcare InstituteCompleted
Clinical Trials on Greenness as a therapeutic intervention
-
Charite University, Berlin, GermanyUniversity Hospital, SaarlandUnknownFirst Ischemic StrokeGermany
-
Brown UniversityButler HospitalCompleted
-
Chinese University of Hong KongCity University of Hong KongCompleted
-
Oslo University HospitalHelse Sor-OstActive, not recruiting
-
BERTHILLIER JulienCompletedNeurological Disorder
-
Rabin Medical CenterRecruitingSuicide, AttemptedIsrael
-
Beijing Tiantan HospitalCompletedAcute Kidney Injury | Risk Factor | EpidemiologyChina
-
Nicoline LøkkenCompleted
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedSubstance AbuseUnited States
-
Geriatric Education and Research InstituteSingapore General Hospital; Changi General Hospital; Sengkang General Hospital; Alexandra Hospital and other collaboratorsCompletedFrail Elderly Syndrome | Frailty | Frailty SyndromeSingapore